Hyperion Defi, Inc.
HYPD- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001682639
No open-market purchases or sales by Hyperion Defi, Inc. insiders were filed in the last 90 days; 33 institutions reported holding it in 13F filings for Q2 2026, worth $7.92M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Hyperion Defi, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 26 | 28 | +2 |
| Shares | 1.92M | 1.97M | +41.5K (+2.2%) |
| Value | $9.44M | $7.86M | −$1.59M (−16.8%) |
New holders (8)
Institutions that held Hyperion Defi, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| AMH Equity Ltd | 100,000 | $400.0K | 0.58% |
| Marshall Wace, LLP | 53,810 | $216.0K | 0.00% |
| Norris Financial Group, LLC | 24,515 | $98.1K | 0.06% |
| Citadel Advisors LLC | 10,598 | $43.0K | 0.00% |
| LPL Financial LLC | 10,600 | $42.0K | 0.00% |
| American Portfolios Advisors | 2,000 | $8.00K | 0.00% |
| Cutler Group LP | 800 | $3.00K | 0.00% |
| Tower Research Capital LLC (TRC) | 108 | $0 | 0.00% |
Sold out (6)
Institutions that held Hyperion Defi, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Two Sigma Investments, LP | 80,847 | $396.0K |
| Acadian Asset Management LLC | 32,446 | $157.0K |
| Wealthcare Advisory Partners LLC | 10,000 | $49.0K |
| Valeo Financial Advisors, LLC | 10,000 | $49.0K |
| Deutsche Bank AG | 1 | $0 |
| O'Shaughnessy Asset Management, LLC | 82 | $0 |